Get informed when a big investor buys or sells
+ Follow0.10
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
Profound Medical (PROF) currently reports a debt-to-equity ratio of 0.1. That is above the Healthcare sector average of -8.5. Use the charts on this page to explore Profound Medical's debt-to-equity ratio history and peer comparisons.
Profound Medical's debt-to-equity ratio of 0.1 is higher than the Healthcare sector average of -8.5. That is roughly 101.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The debt-to-equity ratio is a valuation multiple that relates Profound Medical's market price to a fundamental measure such as earnings, sales, or book value. At 0.1, PROF can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current debt-to-equity ratio of 0.1, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -8.5. From there, open related valuation or income-statement pages for Profound Medical, and consider following PROF for alerts when major investors trade the stock.
Profound Medical is classified in the Healthcare sector. On debt-to-equity ratio, it currently shows 0.1 versus a sector average near -8.5. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PROF with unrelated industries.